Source: International Congress 2016 – Severe respiratory infections in the intensive care unit and pleural and fungal infections
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
Anant Mohan (New Delhi, India), Anant Mohan, Pawan Tiwari, Rosemary Poulose, Karan Madan, Vijay Hadda, Ashu Seith, Rohit Khandelwal, G.C. Khilnani, Randeep Guleria. Intrabronchial voriconazole instillation provides effective hemoptysis control in inoperable pulmonary aspergilloma. Eur Respir J 2016; 48: Suppl. 60, 2644

Member's Comments

No comment yet.

Related content which might interest you: Treatment of hemoptysis in inoperable patients with pulmonary aspergilloma: Value of percutaneous instillation of fluconazole Source: Annual Congress 2013 –Interesting cases of respiratory infections Year: 2013 Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma Source: Eur Respir J 2011; 37: 865-872 Year: 2011 Chronic pulmonary aspergillosis in patients with post-tuberculosis bronchiectasis Source: International Congress 2018 – Pulmonary tuberculosis: long term complications, rehabilitation and challenges Year: 2018 Thoracoplasty in the treatment of chronic nonspecific empyema Source: Annual Congress 2012 - Special problems in thoracic surgery Year: 2012 Chronic pulmonary aspergillosis commonly complicates treated pulmonary tuberculosis with residual cavitation Source: Eur Respir J, 53 (3) 1801184; 10.1183/13993003.01184-2018 Year: 2019 The surgical treatment of pulmonary aspergillomas Source: Eur Respir J 2001; 18: Suppl. 33, 459s Year: 2001 Surgical approach in pulmonary aspergilloma Source: Eur Respir J 2004; 24: Suppl. 48, 628s Year: 2004 Surgery treatment of pulmonary aspergillosis Source: Annual Congress 2007 - Surgical management of thoracic infections and issues in respiratory physiology Year: 2007 Prophylactic antibiotics will affect the occurrence of post-bronchoscopic fever and pneumonia in patient with endobronchial obstructive lesions? Source: Annual Congress 2007 - Infectious lung and pleural diseases Year: 2007 Non-bronchial systemic arterial embolization in management of massive hemoptysis secondary to post-tuberculous bronchiectasis in Egypt Source: Annual Congress 2010 - Vascular and solitary lesions Year: 2010 Caspofungin to treat invasive pulmonary aspergillosis in sarcoidosis Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections Year: 2012 Pulmonary resection in the treatment of massive hemoptysis Source: Annual Congress 2013 –Surgery for pleuropulmonary and mediastinal benign diseases Year: 2013 Bronchoscopic intrabullous endobronchial autologous blood instillation (BIABI) for the treatment of giant bullae Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going? Year: 2013 Chronic pulmonary aspergillosis complicating sarcoidosis Source: Eur Respir J, 49 (6) 1602396; 10.1183/13993003.02396-2016 Year: 2017 Predictor of success in endobronchial occlusion therapy against intractable pneumothoraces Source: International Congress 2015 – Interventional pulmonology for pleural diseases Year: 2015 Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary diseases Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013 Bronchoscopic intrabullous autologous blood instillation (BIABI) for the treatment of severe bullous emphysema Source: International Congress 2014 – Bronchoscopic treatment of emphysema: where are we? Year: 2014 Diagnosis and treatment of invasive pulmonary aspergillosis in neutropenic patients Source: Eur Respir J 2001 Jan 01;19(4):743-755 Year: 2002